Pasithea Therapeutics Corp. (KTTAW) Exchange Rate Effect (2021 - 2026)

Pasithea Therapeutics has disclosed Exchange Rate Effect across 6 years of filings, most recently posting -$37328.0 for Q2 2026.

• In Q2 2026, Exchange Rate Effect changed N/A year-over-year to -$37328.0; the TTM figure through Jun 2026 stood at $3939.0 (changed N/A YoY), while the FY2025 annual figure was $18766.0, up 844.98% from the prior year.
• Exchange Rate Effect came in at -$37328.0 for Q2 2026 at Pasithea Therapeutics, down from $28132.0 in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $139421.0 in Q4 2022 to a low of -$82515.0 in Q3 2022.
• Average Exchange Rate Effect over 5 years is $458.06, with a median of -$1551.5 recorded in 2023.
• The largest YoY upside for Exchange Rate Effect was 2150.61% in 2022 against a maximum downside of 5590.69% in 2022.
• Over 5 years, Exchange Rate Effect stood at $139421.0 in 2022, then plunged by 97.8% to $3065.0 in 2023, then soared by 818.3% to $28146.0 in 2024, then plunged by 98.35% to $465.0 in 2025, then sank by 8127.53% to -$37328.0 in 2026.
• Per Business Quant data, the three most recent Exchange Rate Effect figures were -$37328.0 in Q2 2026, $28132.0 in Q1 2026, and $465.0 in Q4 2025.